SHUKRAPHAR vs TATAPOWER: Stock Comparison

Head-to-head financial and trading comparison between Shukra Pharmaceuticals Limited (SHUKRAPHAR) and Tata Power Company Limited (TATAPOWER) in the Cross-Sector Peers sector.

SHUKRAPHAR

NSE: SHUKRAPHAR
Shukra Pharmaceuticals Limited
₹66.94
1Y Return: +61.61%
52W High: ₹72.58
52W Low: ₹41.42
Annual Volatility: 64.68%
Check SHUKRAPHAR Trade Fees →

TATAPOWER

NSE: TATAPOWER
Tata Power Company Limited
₹342.15
1Y Return: -21.09%
52W High: ₹461.80
52W Low: ₹335.65
Annual Volatility: 23.17%
Check TATAPOWER Trade Fees →

Key Metrics Comparison Table

MetricSHUKRAPHARTATAPOWEREdge / Winner
Current Market Price (CMP) ₹66.94 ₹342.15 —
1-Year Price Return +61.61% -21.09% SHUKRAPHAR (82.70% higher)
52-Week High ₹72.58 ₹461.80 —
52-Week Low ₹41.42 ₹335.65 —
30-Day Annualized Volatility 64.68% 23.17% TATAPOWER (Steadier)
30-Day Average Daily Volume 6,592,919 4,808,998 SHUKRAPHAR (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between SHUKRAPHAR and TATAPOWER, which stock gave better returns over the last year?

SHUKRAPHAR has outperformed TATAPOWER over the past 12 months with a gain of 61.61% compared to -21.09%.

Which stock is less volatile: SHUKRAPHAR or TATAPOWER?

TATAPOWER demonstrated lower price volatility (23.17% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of SHUKRAPHAR vs TATAPOWER?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are SHUKRAPHAR and TATAPOWER direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.